INS1007 ( DrugBank: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
44	多発血管炎性肉芽腫症	1
299	嚢胞性線維症	24

44. 多発血管炎性肉芽腫症

臨床試験数 : 92 / 薬物数 : 106 - (DrugBank : 27) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 78

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-003903-21-FR (EUCTR)	04/06/2019	19/02/2019	A Study to Assess the pharmacokinetics and pharmacodynamics of INS1007Administered Once Daily in Pat ...	A Randomized, Single-Blind Study to Evaluate the Pharmacokinetics (PK), and Pharmacodynamics (PD) of ...	Granulomatosis with Polyangiitis (GPA MedDRA version: 20.0;Level: PT;Classification code 10072579;Te ...	Product Name: INS1007 INN or Proposed INN: Not available Other descriptive name: AZD7986 Product Name: ...	Insmed Incorporated	NULL	Not Recruiting			Female: yes Male: yes	16	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	France

First Previous1Next Last

299. 嚢胞性線維症

臨床試験数 : 1,696 / 薬物数 : 1,644 - (DrugBank : 272) / 標的遺伝子数 : 96 - 標的パスウェイ数 : 170

diseases per page:

Showing 1 to 10 of 24 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-003688-25-SK (EUCTR)	01/06/2021	10/12/2020	A study to evaluate the effects of Brensocatib Administered Once Daily for 52 Weeks in Subjects with ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and To ...	Non-Cystic Fibrosis Bronchiectasis MedDRA version: 23.0;Level: LLT;Classification code 10083611;Term ...	Product Name: Brensocatib Product Code: INS1007 INN or Proposed INN: Brensocatib Other descriptive name ...	Insmed Incorporated	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	1660	Phase 3	Portugal;Serbia;United States;Estonia;Taiwan;Slovakia;Greece;Spain;Thailand;Ukraine;Ireland;Israel;C ...
2	EUCTR2020-003688-25-DE (EUCTR)	08/04/2021	12/10/2020	A study to evaluate the effects of Brensocatib Administered Once Daily for 52 Weeks in Subjects with ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and To ...	Non-Cystic Fibrosis Bronchiectasis MedDRA version: 23.0;Level: LLT;Classification code 10083611;Term ...	Product Name: Brensocatib Product Code: INS1007 INN or Proposed INN: Brensocatib Other descriptive name ...	Insmed Incorporated	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	1620	Phase 3	Portugal;Serbia;United States;Taiwan;Estonia;Slovakia;Greece;Spain;Thailand;Ukraine;Ireland;Russian ...
3	EUCTR2020-003688-25-LT (EUCTR)	05/03/2021	07/12/2020	A study to evaluate the effects of Brensocatib Administered Once Daily for 52 Weeks in Subjects with ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and To ...	Non-Cystic Fibrosis Bronchiectasis MedDRA version: 23.0;Level: LLT;Classification code 10083611;Term ...	Product Name: Brensocatib Product Code: INS1007 INN or Proposed INN: Brensocatib Other descriptive name ...	Insmed Incorporated	NULL	Not Recruiting	Female: yes Male: yes	1620	Phase 3	Portugal;Serbia;United States;Taiwan;Estonia;Slovakia;Greece;Spain;Thailand;Ukraine;Ireland;Russian ...
4	EUCTR2020-003688-25-EE (EUCTR)	01/03/2021	06/01/2021	A study to evaluate the effects of Brensocatib Administered Once Daily for 52 Weeks in Subjects with ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and To ...	Non-Cystic Fibrosis Bronchiectasis MedDRA version: 23.0;Level: LLT;Classification code 10083611;Term ...	Product Name: Brensocatib Product Code: INS1007 INN or Proposed INN: Brensocatib Other descriptive name ...	Insmed Incorporated	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	1620	Phase 3	Portugal;Serbia;United States;Estonia;Taiwan;Slovakia;Greece;Spain;Thailand;Ukraine;Ireland;Israel;C ...
5	EUCTR2020-003688-25-AT (EUCTR)	11/02/2021	10/12/2020	A study to evaluate the effects of Brensocatib Administered Once Daily for 52 Weeks in Subjects with ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and To ...	Non-Cystic Fibrosis Bronchiectasis MedDRA version: 23.0;Level: LLT;Classification code 10083611;Term ...	Product Name: Brensocatib Product Code: INS1007 INN or Proposed INN: Brensocatib Other descriptive name ...	Insmed Incorporated	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	1620	Phase 3	Portugal;Serbia;United States;Taiwan;Estonia;Slovakia;Greece;Spain;Thailand;Ukraine;Ireland;Russian ...
6	EUCTR2020-003688-25-BG (EUCTR)	27/01/2021	04/12/2020	A study to evaluate the effects of Brensocatib Administered Once Daily for 52 Weeks in Subjects with ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and To ...	Non-Cystic Fibrosis Bronchiectasis MedDRA version: 23.0;Level: LLT;Classification code 10083611;Term ...	Product Name: Brensocatib Product Code: INS1007 INN or Proposed INN: Brensocatib Other descriptive name ...	Insmed Incorporated	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	1660	Phase 3	United States;Serbia;Portugal;Taiwan;Estonia;Slovakia;Greece;Thailand;Spain;Ukraine;Ireland;Israel;C ...
7	EUCTR2020-003688-25-IE (EUCTR)	18/01/2021	30/10/2020	A study to evaluate the effects of Brensocatib Administered Once Daily for 52 Weeks in Subjects with ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and To ...	Non-Cystic Fibrosis Bronchiectasis MedDRA version: 23.0;Level: LLT;Classification code 10083611;Term ...	Product Name: Brensocatib Product Code: INS1007 INN or Proposed INN: Brensocatib Other descriptive name ...	Insmed Incorporated	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	1620	Phase 3	Portugal;Serbia;United States;Taiwan;Estonia;Slovakia;Greece;Spain;Thailand;Ukraine;Ireland;Russian ...
8	EUCTR2020-003688-25-IT (EUCTR)	15/01/2021	15/06/2021	A study to evaluate the effects of Brensocatib Administered Once Daily for 52 Weeks in Subjects with ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and To ...	Non-Cystic Fibrosis Bronchiectasis MedDRA version: 21.0;Level: PT;Classification code 10006445;Term: ...	Product Name: Brensocatib Product Code: [INS1007] INN or Proposed INN: Brensocatib Product Name: Brenso ...	INSMED INCORPORATED	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	1620	Phase 3	Portugal;Serbia;United States;Taiwan;Slovakia;Greece;Spain;Thailand;Ukraine;Ireland;Russian Federati ...
9	EUCTR2020-003688-25-PT (EUCTR)	15/01/2021	16/10/2020	A study to evaluate the effects of Brensocatib Administered Once Daily for 52 Weeks in Subjects with ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and To ...	Non-Cystic Fibrosis Bronchiectasis MedDRA version: 23.0;Level: LLT;Classification code 10083611;Term ...	Product Name: Brensocatib Product Code: INS1007 INN or Proposed INN: Brensocatib Other descriptive name ...	Insmed Incorporated	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	1620	Phase 3	Turkey;Austria;United Kingdom;Hungary;Mexico;Canada;Argentina;Poland;Brazil;Belgium;Croatia;Bulgaria ...
10	EUCTR2020-003688-25-BE (EUCTR)	15/01/2021	15/01/2021	A study to evaluate the effects of Brensocatib Administered Once Daily for 52 Weeks in Subjects with ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and To ...	Non-Cystic Fibrosis Bronchiectasis MedDRA version: 23.0;Level: LLT;Classification code 10083611;Term ...	Product Name: Brensocatib Product Code: INS1007 INN or Proposed INN: Brensocatib Other descriptive name ...	Insmed Incorporated	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	1620	Phase 3	United States;Serbia;Portugal;Taiwan;Estonia;Slovakia;Greece;Thailand;Spain;Ukraine;Ireland;Russian ...

First Previous1 2 3Next Last

先頭へ